The FINANCIAL - Health & Beauty

Michael R. Bloomberg Becomes WHO Global Ambassador for Noncommunicable Diseases

The FINANCIAL -- WHO has on August 17 named Mr Michael R. Bloomberg, philanthropist and former three-term Mayor of the City of New York, as Global Ambassador for Noncommunicable Diseases ...

Caring for Alzheimer’s Patients

The FINANCIAL -- There once was a man who mistook his wife for a hat. In his book, The Man Who Mistook His Wife For A Hat, renowned neurologist Dr. Oliver Sacks recounts the case histories of ...

Statins could reduce risk of dying from four most common cancers

The FINANCIAL -- Statins may significantly cut the risk of dying from the four most common cancers, ground breaking Aston University research has ...

New European Consortium launched to fight eye cancer

The FINANCIAL -- The University of Liverpool’s Institute of Translational Medicine will be a partner in a new European Consortium to foster research on eye cancer and identify new treatments for ...

Bayer and White Ribbon Alliance Announce Self-Care Policy Recommendations and Programs to Support Maternal, Newborn and Child Health

The FINANCIAL -- With 830 women dying every day from preventable causes related to pregnancy and childbirth, and over 16,000 children under age five dying daily, Bayer and the White Ribbon Alliance ...

L'Oréal USA Launches Beaumoji, the Ultimate Emoji Keyboard for Beauty Lovers

The FINANCIAL -- L’Oréal USA on July 14 announced the launch of “Beaumoji,” the most extensive messaging keyboard designed to enhance and animate conversations around the world of beauty. The ...

Scientists conduct largest ever study of HIV transmission

The FINANCIAL -- A new study has found that neither gay men nor heterosexual people with HIV transmit the virus to their partner, provided they are on suppressive antiretroviral ...

Allergan Files Application to FDA for Approval of Oculeve Intranasal Tear Neurostimulator

The FINANCIAL -- Allergan plc announced on July 18, that it has filed with the U.S. Food and Drug Administration (FDA) the de novo application for the Oculeve Intranasal Tear Neurostimulator device. ...

Corneal Transplants, Men and Women Don’t See Eye to Eye

The FINANCIAL -- A new study of patients undergoing corneal transplants indicates that subtle differences between men and women may lead to poorer outcomes for a woman who has received a cornea from ...

Partnership launched to study impact of dog-bites

The FINANCIAL -- A new multi-disciplinary partnership has been launched to help address the problem of dog-bites in Merseyside, which has the highest number of dog-related injuries and deaths in the ...

As overweight and obesity increase, so does risk of dying prematurely

The FINANCIAL -- Being overweight or obese is associated with a higher risk of dying prematurely than being normal weight—and the risk increases with additional pounds, according to a large ...

Researchers develop tool to treat child hip diseases

The FINANCIAL -- Researchers from the Universities of Liverpool and Manchester have been awarded £278k to help investigate the best surgical treatments for hip diseases in ...

True magnitude of stillbirths and maternal and neonatal deaths underreported

The FINANCIAL -- The day of birth is potentially the most dangerous time for mothers and babies. Every year, worldwide, 303 000 women die during pregnancy and childbirth, 2.7 million babies die ...

Patients and Healthcare Professionals Divided on Responsibility and Cost in Healthcare

The FINANCIAL -- Healthcare research released on August 15 from Xerox shows large disconnects between patients and healthcare professionals providing and insuring their care. This research suggests ...

China facing epidemic of heart disease, stroke

The FINANCIAL -- A 20-year rise in cardiovascular disease (CVD) in China appears to have been spurred largely by increases in high blood pressure, according to a new study from Harvard T.H. Chan ...

Government of Nigeria reports 2 wild polio cases, first since July 2014

The FINANCIAL -- After more than two years without wild poliovirus in Nigeria, the Government reported on August 11 that 2 children have been paralyzed by the disease in the northern Borno ...

Fusobacteria use a special sugar-binding protein to bind to colon tumors

The FINANCIAL -- Some bacteria, called fusobacteria, commonly found in the mouth, use a sugar-binding protein to stick to developing colorectal polyps and cancers, according to a new study by ...

Prevalence of life-threatening neural tube defects on the rise

The FINANCIAL -- Every year, around eight million babies are affected by birth defects globally. These include life-debilitating neural tube defects (NTDs) which result in devastating conditions such ...

Unsafe levels of toxic chemicals found in drinking water for six million Americans

The FINANCIAL -- Levels of a widely used class of industrial chemicals linked with cancer and other health problems—polyfluoroalkyl and perfluoroalkyl substances (PFASs)—exceed federally ...

University leads diet drinks study to tackle obesity

The FINANCIAL -- The University of Liverpool is running the largest ever investigation into artificially sweetened drinks and their effect on weight loss and weight ...

Percentage of Pack-a-Day Smokers Hits Record Low in U.S.

The FINANCIAL -- The percentage of smokers in the U.S. who light up a pack or more of cigarettes a day has fallen sharply over the past decade and is now at an all-time low of 26% in Gallup's ...

£1m obesity and type 2 diabetes clinical trial launched

The FINANCIAL -- A major clinical trial involving patients with obesity and type 2 diabetes, led by researchers from across the University of Liverpool has been funded £1 ...

Promising Alzheimer’s research takes a step forward

The FINANCIAL -- Scientists from the University of Liverpool and Victoria University of Wellington have been awarded over £478K to advance a potential treatment for Alzheimer’s ...

Bristol-Myers Squibb Announces New Research Collaboration with Janssen in Immuno-Oncology Focused on Lung Cancer

The FINANCIAL -- Bristol-Myers Squibb Company today announced a new clinical research collaboration with Janssen Biotech, Inc. to evaluate Bristol-Myers Squibb’s Immuno-Oncology (I-O) agent Opdivo ...

Other

User pages

Main Menu